Ennovance Capital is a niche industry-focused investor in middle-market products and services companies. We exclusively focus on the chemical, allied product, specialty materials, health-care and general chemistry related sectors (addressable market > $4.4 trillion).
End markets for related products and services in these industries vary widely such as: water and waste treatment, functional additives, renewable energy, fine chemicals, medical device or electronics, biodegradable plastics, coatings, food, flavor, fragrance and beverage, beauty & personal care, hygiene & cleaning solutions for hospitals or general application, preservatives, fertilizer, catalyst and so on. We also like niche manufactured equipment, and services business related to chemistry such as contract manufacturing, contract research, laboratory supplies, safety or security solutions etc.
We focus on structuring acquisitions that meet the unique requirements of each strategic seller, navigating all aspects of deal complexities. From public-to-private transactions to corporate divestitures of non-core assets, we're skilled at mitigating all degrees of risk when extracting a non-core division from its parent, maintaining business momentum, and ensuring business continuity. We utilize a multi-disciplinary approach to investing, and implement various growth and margin initiatives in combination with the operating management team.
For more information, please visit: www.ennovance.com
Specialties
Buyouts, Growth Capital, Recapitalizations, Turnarounds, Private equity investment, Alternative asset investment, leveraged buyout, Operational value creation, Chemical, health care, Marcellus Shale Gas, Clean technology, Joint Venture, PIPE, Energy, Water
